SCHEMBL9949996

SCHEMBL9949996

c1ccc(-c2c3ccccc3c(-c3ccc(-c4cc5ccccc5c5c4oc4ccccc45)cc3)c3ccccc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
ALDH1A1 P00352 2/20 0.43
RAB9A P51151 2/20 0.43
MAOB P27338 1/20 0.43
GPR84 Q9NQS5 6/20 0.43
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
CDC14B O60729 2/20 0.41
CDC14A Q9UNH5 2/20 0.41
ALOX5 P09917 2/20 0.40
RECQL P46063 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ADORA2A P29274 1/20 0.39
CYP1A1 P04798 1/20 0.38
CYP1A2 P05177 1/20 0.38
FYN P06241 1/20 0.38
MAPK3 P27361 1/20 0.38
AHR P35869 1/20 0.38
PAX8 Q06710 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10130436 0.93 GPR84 (0.41) KDM4EALDH1A1RAB9AMAOBGPR84
SCHEMBL10130437 0.93 GPR84 (0.41) KDM4EALDH1A1RAB9AMAOBGPR84
SCHEMBL10130478 0.93 GPR84 (0.41) KDM4EALDH1A1RAB9AMAOBGPR84
SCHEMBL9951354 0.93 GPR84 (0.41) KDM4EALDH1A1RAB9AMAOBGPR84
SCHEMBL9952160 0.93 TDP1 (0.39) KDM4EALDH1A1RAB9AMAOBGPR84
SCHEMBL10130476 0.93 GPR84 (0.40) KDM4EALDH1A1RAB9AMAOBGPR84
SCHEMBL10130468 0.93 ALOX5 (0.41) KDM4EALDH1A1RAB9AMAOBGPR84
SCHEMBL9950424 0.92 KDM4E (0.49) KDM4EALDH1A1RAB9AMAOBGPR84
SCHEMBL29363031 0.92 KDM4E (0.49) KDM4EALDH1A1RAB9AMAOBGPR84
SCHEMBL10130465 0.92 ALOX5 (0.40) KDM4EALDH1A1RAB9AMAOBGPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260136832-A1 Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2026-05-14 US disclosed
US-20210242409-A1 Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2021-08-05 US disclosed
US-20210242409-A1 Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2021-08-05 US disclosed
US-8604224-B2 Benzo[b]naphtho[1,2-d]furan compound as light-emitting element material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2013-12-10 US disclosed
US-20120165556-A1 Benzo[b]Naphtho[1,2-d]Furan Compound as Light-Emitting Element Material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-06-28 US disclosed
US-20120165556-A1 Benzo[b]Naphtho[1,2-d]Furan Compound as Light-Emitting Element Material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-06-28 US disclosed
US-20120165556-A1 Benzo[b]Naphtho[1,2-d]Furan Compound as Light-Emitting Element Material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260136832-A1 Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device CYBA, SUN2, CYBB KDM4E 1960/4885ALDH1A1 93/4885RAB9A 3266/4885
US-20120165556-A1 Benzo[b]Naphtho[1,2-d]Furan Compound as Light-Emitting Element Material CYP1B1, CTNND1, CTNNB1 KDM4E 3607/4885ALDH1A1 64/4885RAB9A 822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.